Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Daniela Drago, PhD, RAC, FRAPS

Partner
NDA Partners

Daniela Drago, Ph.D., RAC, FRAPS, is a Partner at NDA Partners. During her career, Daniela has held senior global regulatory and medical affairs positions at Roche, Biogen, Vifor Pharma, Reckitt Benckiser, and Bausch & Lomb. She was formerly an Associate Professor at George Washington University’s School of Medicine, where she also directed the regulatory affairs and the clinical & translational research programs. She has significant domestic and international experience developing small molecules, biologics, gene therapies, and combination products in many rare and common disease areas. In recognition of her achievements, Daniela received several awards, including the TOPRA Award for Regulatory Excellence and the RAPS Community Leadership Award. Currently, she serves on the RAPS Board of Directors, the Executive Committee of the American Course in Drug Development and Regulatory Science (ACDRS), and the Regulatory Affairs Committee of the American Society of Gene and Cell Therapy (ASGCT). Daniela is a Fellow of the Regulatory Affairs Professional Society (FRAPS) and of the Organisation for Professionals in Regulatory Affairs (FTOPRA). She received her Ph.D. in chemistry from the Swiss Federal Institute of Technology (ETH) in Zurich.

Disclosure information not submitted.

Presentation(s):